Normal values for calprotectin in stool samples of infants from the population-based longitudinal born into life study

References

• Apley J, Naish N. Recurrent abdominal pains: a field survey of 1,000 school children. Arch Dis Child. 1958;33:165–170.
   PubMed Web of Science ®Google Scholar
• Balani B, Patwari A K, Bajaj P, et al. Recurrent abdominal pain-a reappraisal. Ind Pediatr. 2000;37:876–881.
   PubMedGoogle Scholar
• Virta LJ, Saarinen MM, Kolho K L. Inflammatory bowel disease incidence is on the continuous rise among all paediatric patients except for the very young: a nationwide registry-based study on 28-year follow-up. J Crohns Colitis..2017;11:150–156.
   PubMed Web of Science ®Google Scholar
• Larsen MD, Baldal ME, Nielsen RG, et al. The incidence of Crohn’s disease and ulcerative colitis since 1995 in Danish children and adolescents <17 years – based on nationwide registry data. Scand J Gastroenterol. 2016;51:1100–1105.
   PubMed Web of Science ®Google Scholar
• Langhorst J, Elsenbruch S, Koelzer J, et al. Non-invasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-Elastase, CRP, and clinical indices. Am J Gastroenterol. 2008;103:162–169.
   PubMed Web of Science ®Google Scholar
• Chatzikonstantinou M, Konstantopoulos P, Stergiopoulos S, et al. Calprotectin as a diagnostic tool for inflammatory bowel diseases. Biomed Rep. 2016;5:403–407.
   PubMed Web of Science ®Google Scholar
• Holtman GA, Lisman-van Leeuwen Y, Day AS, et al. Use of laboratory markers in addition to symptoms for diagnosis of inflammatory bowel disease in children: a meta-analysis of individual patient data. JAMA Pediatr. 2017;171:984–991.
   PubMed Web of Science ®Google Scholar
• Van de Vijver E, Schreuder AB, Cnossen WR, et al. Safely ruling out inflammatory bowel disease in children and teenagers without referral for endoscopy. Arch Dis Child. 2012;97:1014–1018.
   PubMed Web of Science ®Google Scholar
• Orivuori L, Mustonen K, de Goffau MC, et al. High level of faecal calprotectin at age 2 months as a marker of intestinal inflammation predicts atopic dermatitis and asthma by age 6. Clin Exp Allergy. 2015;45:928–939.
   PubMed Web of Science ®Google Scholar
• Duman M, Gencpinar P, Bicmen M, et al. Faecal calprotectin: can be used to distinguish between bacterial and viral gastroenteritis in children? Am J Emerg Med. 2015;33:1436–1439.
   PubMed Web of Science ®Google Scholar
• Fagerhol MA, Naess-Andresen CF, Brandtzaeg P, Dale I. Calprotectin (the L1 leukocyte protein). In: Smith V, Dedman, JR, editor. Stimulus response coupling: the role of intracellular calcium-binding proteins. Boca Raton (FL): CRC Press Inc.; 1990. p. 187–210.
   Google Scholar
• Dale I, Brandtzaeg P, Fagerhol MK, et al. Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. Am J Clin Pathol. 1985;84:24–34.
   PubMed Web of Science ®Google Scholar
• Røseth AG, Schmidt PN, Fagerhol MK. Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. Scand J Gastroenterol. 1999;34:50–54.
   PubMed Web of Science ®Google Scholar
• Nilsen T, Sunde K, Hansson LO, et al. A novel turbidimetric immunoassay for faecal calprotectin optimised for routine chemistry analysers. J Clin Lab Anal. 2017;31:e22061.
   Web of Science ®Google Scholar
• Smew AI, Hedman AM, Chiesa F, et al. Limited association between markers of stress during pregnancy and fetal growth in “Born into Life”, a new prospective birth cohort. Acta Paediatrica. In Press.
   Google Scholar
• Almqvist C, Adami HO, Franks PW, et al. LifeGene–a large prospective population-based study of global relevance. Eur J Epidemiol. 2011;26:67–77.
   PubMed Web of Science ®Google Scholar
• Protudjer JL, Vetander M, Kull I, et al. Food-related symptoms and food allergy in Swedish children from early life to adolescence. PLoS One. 2016;11:e0166347.
   PubMed Web of Science ®Google Scholar
• Broberg A, Svensson A, Borres MP, et al. Atopic dermatitis in 5–6-year-old Swedish children: cumulative incidence, point prevalence, and severity scoring. Allergy. 2000;55:1025–1029.
   PubMed Web of Science ®Google Scholar
• Örtqvist AK, Lundholm C, Kieler H, et al. Antibiotics in fetal and early life and subsequent childhood asthma: nationwide population based study with sibling analysis. BMJ. 2014;349:g6979.
   PubMed Web of Science ®Google Scholar
• Socialstyrelsen. Statistics on inpatient diseases in Sweden 2016. 2017 Available from: http://www.socialstyrelsen.se/publikationer2017/2017-9-7
   Google Scholar
• Whitehead SJ, French J, Brookes MJ, et al. Between-assay variability of faecal calprotectin enzyme-linked immunosorbent assay kits. Ann Clin Biochem. 2013;50:53–61.
   PubMed Web of Science ®Google Scholar
• Horn PS, Feng L, Li Y, et al. Effect of outliers and nonhealthy individuals on reference interval estimation. Clin Chem. 2001;47:2137–2145.
   PubMed Web of Science ®Google Scholar
• Campeotto F, Butel MJ, Kalach N, et al. High faecal calprotectin concentrations in newborn infants. Arch Dis Child Fetal Neonatal Ed. 2004;89:F353–F355.
   PubMed Web of Science ®Google Scholar
• Li F, Ma J, Geng S, et al. Faecal calprotectin concentrations in healthy children aged 1–18 months. PLoS One. 2015;10:e0119574.
   PubMed Web of Science ®Google Scholar
• Dorosko SM, MacKenzie T, Connor RI. Fecal calprotectin concentrations are higher in exclusively breastfed infants compared to those who are mixed-fed. Breastfeed Med. 2008;3:117–U25.
   PubMed Web of Science ®Google Scholar
• Poullis A, Foster R, Shetty A, et al. Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2004;13:279–284.
   PubMed Web of Science ®Google Scholar
• Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008;134: 577–594.
   PubMed Web of Science ®Google Scholar
• Li F, Ma J, Geng S, et al. Comparison of the different kinds of feeding on the level of faecal calprotectin. Early Hum Dev. 2014;90:471–475.
   PubMed Web of Science ®Google Scholar
• Havelaar AH, Kirk MD, Torgerson PR, World Health Org Foodborne Dis B, et al. World Health Organization global estimates and regional comparisons of the Burden of foodborne disease in 2010. PLoS Med. 2015;12:23.
   Web of Science ®Google Scholar
• Chen CC, Huang JL, Chang CJ, et al. Faecal calprotectin as a correlative marker in clinical severity of infectious diarrhea and usefulness in evaluating bacterial or viral pathogens in children. J Pediatr Gastroenterol Nutr. 2012;55:541–547.
   PubMed Web of Science ®Google Scholar
• Czub E, Nowak JK, Moczko J, et al. Comparison of faecal pyruvate kinase isoform M2 and calprotectin in acute diarrhea in hospitalized children. Sci Rep. 2014;4:4769.
   PubMed Web of Science ®Google Scholar